NFKB1 and Miyoshi myopathy: Considering that IKKβ is the most abundant and important IKK in MM, inhibition of IKKβ by JA is a promising strategy to inhibit the NF-κB pathway in MM, suggesting that JA may be an effective treatment for MM patients.